Russia is committing $26 billion to an ambitious anti-aging program called ‘New Health Preservation Technologies,’ which aims to slow the aging process and enhance human longevity. This initiative includes cutting-edge approaches such as gene therapies that target cellular aging, xenotransplantation—growing human organs in pigs—and 3D bioprinting of living tissues. Notable early advancements include the successful printing of human cartilage and a mouse thyroid gland, with aspirations to create transplant-ready human organs on demand. Maria Vorontsova, an endocrinologist and daughter of President Vladimir Putin, is playing a pivotal role in guiding this research. However, the project faces skepticism from critics who question the scientific basis of its claims, pointing out the absence of peer-reviewed studies in reputable journals. Alexander Ostrovskiy, a pioneer in Russian bioprinting, has labeled the initiative as “aspirational,” emphasizing the need for validation. As scrutiny of Putin’s public appearances continues, the initiative raises questions about whether it represents a genuine scientific breakthrough or merely an extravagant experiment in anti-aging.